Domov › Alzheimerjeva bolezen › North Carolina
Klinične študije za Alzheimerjeva bolezen v North Carolina
21 študij za Alzheimerjeva bolezen išče udeležence na lokacijah v North Carolina.
Mesta v North Carolina
Uradno besedilo študije (angleško)
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- AMC Research, LLC, Matthews
Vključevanje udeležencevFaza 2
Starost 55 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- West Clinical Research, Morehead City
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Triad Clinical Trials - 515 College Rd, Greensboro
- AMC Research, LLC - Flourish - PPDS, Matthews
- West Clinical Research, Morehead City
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Triad Clinical Trials, Greensboro
Vključevanje udeležencevFaza 3
Starost 50–90 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- West Clinical Research, Morehead City
Vključevanje udeležencevFaza 3
Starost 55–90 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07011745ADRC Clinical Cohort (Alzheimer's Disease)
- Duke University, Durham
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 25–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06703541Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- UNC Health REX Hospital, Raleigh
Vključevanje udeležencevFaza 2
Starost 55–90 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- AMC Research, LLC ( Site 1006), Matthews
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
Vključevanje udeležencevFaza 1
Starost 50–85 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- AMC Research, LLC, Matthews
Vključevanje udeležencevFaza 3
Starost 60–85 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06563895A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Flourish Research, Matthews
Vključevanje udeležencevFaza 1/2
Starost 35–85 · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05462106A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Monroe Biomedical Research, Monroe
Vključevanje udeležencevFaza 3
Starost 55 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- UNC Hosp Invest Drug Serv Pharm, Chapel Hill
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT07094516Olfactory Biopsies
- Duke University Health Center, Durham
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT07021040A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Duke Early Phase Research Unit, Durham
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 45–85 · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT06657768Late Onset Alzheimer's Disease
- North Carolina State University, Raleigh
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 55 in več · Vsi spoli · Posodobljeno 18. maj 2026 · NCT05010603Connect-Home: Alzheimer's Disease and Related Dementias
- University of North Carolina at Chapel Hill, Chapel Hill
Vključevanje udeležencev
Starost 19 in več · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT06840587Wake Forest Alzheimer's Disease Clinical Core
- Wake Forest Baptist Health, Winston-Salem
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 55 in več · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT03140865Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 4. feb. 2026 · NCT03233646Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
Vključevanje udeležencevFaza 2
Starost 50–85 · Vsi spoli · Posodobljeno 2. feb. 2026 · NCT07105709Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.